CD16 and Siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells.

As the GI cancer group included pancreatic, colorectal, esophageal, and cholangiocarcinoma cancers, we broke down our findings into individual groups and while not statistically significant, likely due to fewer number of patients in each group, there was a clear trend towards elevated CD16 low Siglec-9 low low-density neutrophils in these cancers ( Figure 5B ). 3.4.

also in 19,460 other papers